We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ESL
226
DELISTED
Esterline Technologies
ESL
| $7.26M | 0.01% |
113,331
| – | – |
2013 Q4
9 quarters
|
|
227
Cabot Corp
CBT
$3.9B
| $7.25M | 0.01% |
150,000
+50,000
| +50% | +$2.15M |
2013 Q2
11 quarters
|
|
228
LyondellBasell Industries
LYB
$20.2B
| $7.21M | 0.01% |
84,300
| – | – |
2013 Q4
9 quarters
|
|
229
Decoy Therapeutics
DCOY
$806K
| $6.96M | 0.01% |
+1
| New | +$8.04M |
2015 Q1
4 quarters
|
|
230
DELISTED
Mobileye N.V.
MBLY
| $6.6M | 0.01% |
177,050
| – | – |
2014 Q3
6 quarters
|
|
231
Greif
GEF
$4.55B
| $6.24M | 0.01% |
190,400
| – | – |
2013 Q2
11 quarters
|
|
232
Expro Ltd
XPRO
$1.76B
| $5.48M | 0.01% |
55,383
| – | – |
2013 Q3
10 quarters
|
|
233
DELISTED
Kellanova
K
| $5.36M | 0.01% |
74,550
| – | – |
2013 Q2
11 quarters
|
|
234
Crown Holdings
CCK
$12.4B
| $5.14M | 0.01% |
103,600
-700
| -0.7% | -$32.9K |
2013 Q2
11 quarters
|
|
235
Lowe's Companies
LOW
$110B
| $5.02M | 0.01% |
+66,300
| New | +$4.68M |
2016 Q1
0 quarters
|
|
236
Arista Networks
ANET
$234B
| $4.76M | ﹤0.01% |
1,208,000
+240,000
| +25% | +$940K |
2014 Q2
7 quarters
|
|
237
Range Resources
RRC
$9.68B
| $4.57M | ﹤0.01% |
141,000
-80,300
| -36% | -$2.23M |
2013 Q2
11 quarters
|
|
|
CBI
238
DELISTED
Chicago Bridge & Iron Nv
CBI
| $4.39M | ﹤0.01% |
120,000
| – | – |
2013 Q2
11 quarters
|
|
|
BRCD
239
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $4.23M | ﹤0.01% |
400,000
-500,000
| -56% | -$4.56M |
2013 Q2
11 quarters
|
|
240
Penumbra
PEN
$12.7B
| $3.99M | ﹤0.01% |
86,800
-14,500
| -14% | -$678K |
2015 Q3
2 quarters
|
|
241
Controladora Vuela Compania de Aviacion
VLRS
$689M
| $3.83M | ﹤0.01% |
182,000
+25,000
| +16% | +$460K |
2013 Q4
9 quarters
|
|
|
CAB
242
DELISTED
Cabela's Inc
CAB
| $3.62M | ﹤0.01% |
74,300
| – | – |
2015 Q3
2 quarters
|
|
|
TWTR
243
DELISTED
Twitter, Inc.
TWTR
| $3.55M | ﹤0.01% |
214,480
| – | – |
2013 Q4
9 quarters
|
|
244
Petrobras Class A
PBR.A
$146B
| $3.15M | ﹤0.01% |
695,000
| – | – |
2013 Q2
11 quarters
|
|
|
FRAN
245
DELISTED
Francesca's Holdings Corporation
FRAN
| $2.93M | ﹤0.01% |
12,733
-384
| -3% | -$82.8K |
2015 Q2
3 quarters
|
|
|
MBII
246
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $2.89M | ﹤0.01% |
3,216,100
-24,100
| -0.7% | -$24.3K |
2013 Q3
10 quarters
|
|
|
CVA
247
DELISTED
Covanta Holding Corporation
CVA
| $2.88M | ﹤0.01% |
171,000
| – | – |
2015 Q4
1 quarter
|
|
|
REXX
248
DELISTED
Rex Energy Corporation
REXX
| $2.81M | ﹤0.01% |
364,500
| – | – |
2013 Q2
11 quarters
|
|
249
Petrobras
PBR
$163B
| $2.51M | ﹤0.01% |
430,000
| – | – |
2013 Q2
11 quarters
|
|
250
DELISTED
Nimble Storage, Inc.
NMBL
| $2.37M | ﹤0.01% |
302,600
+80,000
| +36% | +$569K |
2013 Q4
9 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.